Ampreloxetine: An Investigational, Once-Daily Norepinephrine Reuptake Inhibitor - Emerging Drug Insights and Market Forecasts to 2032: Focus on United States, Germany, France, Italy, Spain UK, & Japan
September 11, 2023 04:23 ET
|
Research and Markets
Dublin, Sept. 11, 2023 (GLOBE NEWSWIRE) -- The "Ampreloxetine Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.This report...
Global Influenza Vaccines Research Analysis Report 2023-2030: Persons Vaccinated, Key Company Analysis, Emerging Players Profile, Vaccines in Clinical Development, Major Deals and Recent Developments
August 31, 2023 10:36 ET
|
Research and Markets
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Influenza Vaccines Market, Persons Vaccinated, Key Company Analysis, Emerging Players Profile, Promising Influenza Vaccines in Clinical...
Global Influenza Vaccines Research Analysis Report 2023-2030: Persons Vaccinated, Key Company Analysis, Emerging Players Profile, Vaccines in Clinical Development, Major Deals and Recent Developments
August 31, 2023 10:34 ET
|
Research and Markets
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Influenza Vaccines Market, Persons Vaccinated, Key Company Analysis, Emerging Players Profile, Promising Influenza Vaccines in Clinical...
Orphan Drugs and Rare Diseases Conference: Life-saving Therapies, Critical Issues, and Strategies to Enhance Orphan Drug Development in near future (London, United Kingdom - October 9-10, 2023)
August 14, 2023 04:13 ET
|
Research and Markets
Dublin, Aug. 14, 2023 (GLOBE NEWSWIRE) -- The "Orphan Drugs and Rare Diseases Conference" conference has been added to ResearchAndMarkets.com's offering. The 4th Annual Orphan Drugs and Rare...
Parkinson's Disease Market Outlook: Epidemiology, Treatment, and Pipeline Analysis
August 10, 2023 09:33 ET
|
Research and Markets
Dublin, Aug. 10, 2023 (GLOBE NEWSWIRE) -- The "Parkinson's Disease by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs,...
RPL554: A First-in-Class, Inhaled, Dual Inhibitor of the PDE3 and PDE4 Enzymes, and Verona Pharma's Lead Pipeline Asset - Emerging Drug Insights and Market Forecasts 2019-2023 & 2023-2032
August 03, 2023 06:58 ET
|
Research and Markets
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "RPL554 Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering. The report offers...
Pitolisant: A Selective Histamine 3 (H3) Receptor Antagonist/Inverse Agonist - Emerging Drug Insight and Market Forecasts, 2019-2023 & 2023-2032
August 03, 2023 06:53 ET
|
Research and Markets
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "Pitolisant Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.This report offers a...
AMO-02 Emerging Drug Insights and Market Forecasts, 2032: Focus on 7 Major Markets - United States, Germany, France, Italy, Spain, United Kingdom, and Japan
August 03, 2023 06:48 ET
|
Research and Markets
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "AMO-02 Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering. The report offers...
Nedosiran Emerging Drug Insight and Market Forecasts, 2032: Focus on 7 Major Markets - United States, Germany, France, Italy, Spain, United Kingdom, and Japan
August 03, 2023 06:43 ET
|
Research and Markets
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "Nedosiran Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering. The report presents...
Avexitide: A 31-amino Acid Peptide that Selectively Targets and Blocks GLP-1 Receptors - Emerging Drug Insights and Market Forecasts, 2019-2022 & 2023-2032
August 01, 2023 06:28 ET
|
Research and Markets
Dublin, Aug. 01, 2023 (GLOBE NEWSWIRE) -- The "Avexitide Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering. "Avexitide Emerging...